Invention Grant
US09333207B2 Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cerebrovascular disease and neurodegenerative diseases of the central nervous system
有权
1-金刚烷基乙氧基-3-吗啉代-2-丙醇或其药学上可接受的盐的药物组合物，用于治疗中枢神经系统的脑血管疾病和神经变性疾病
- Patent Title: Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cerebrovascular disease and neurodegenerative diseases of the central nervous system
- Patent Title (中): 1-金刚烷基乙氧基-3-吗啉代-2-丙醇或其药学上可接受的盐的药物组合物，用于治疗中枢神经系统的脑血管疾病和神经变性疾病
-
Application No.: US14433458Application Date: 2013-09-17
-
Publication No.: US09333207B2Publication Date: 2016-05-10
- Inventor: Gleb Vladimirovich Zagorii
- Applicant: Gleb Vladimirovich Zagorii
- Agency: Alston & Bird LLP
- Priority: UA201211507 20121005; UA201310843 20130909
- International Application: PCT/UA2013/000107 WO 20130917
- International Announcement: WO2014/055055 WO 20140410
- Main IPC: A61K31/5375
- IPC: A61K31/5375
Abstract:
A pharmaceutical composition for parenteral administration containing the active ingredient 1-adamantylethyloxy-3-morpholino-2-propanol, or pharmaceutically acceptable salts thereof, in a concentration range of from 3 to 100 mg/ml for the treatment of cerebrovascular disease.
Public/Granted literature
Information query
